Biogen Accounts Payable vs Operating Expenses Analysis
BIIB Stock | USD 221.50 1.25 0.56% |
Trend analysis of Biogen Inc balance sheet accounts such as Short Long Term Debt Total of 7.7 B, Other Current Liabilities of 969.8 M or Total Current Liabilities of 3.6 B provides information on Biogen's total assets, liabilities, and equity, which is the actual value of Biogen Inc to its prevalent stockholders. By breaking down trends over time using Biogen balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Biogen |
About Biogen Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Biogen Inc at a specified time, usually calculated after every quarter, six months, or one year. Biogen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biogen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biogen currently owns. An asset can also be divided into two categories, current and non-current.
Biogen Balance Sheet Chart
Biogen Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Biogen Inc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, Biogen's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 7.7 B, whereas Cash is forecasted to decline to about 723.1 M. Add Fundamental
Total Assets
Total assets refers to the total amount of Biogen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biogen Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Biogen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biogen Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Biogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. At present, Biogen's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 17.67, whereas Tax Provision is forecasted to decline to about 128.5 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 8.9B | 7.9B | 7.3B | 3.9B | Total Revenue | 11.0B | 10.2B | 9.8B | 10.3B |
Biogen fundamental ratios Correlations
Click cells to compare fundamentals
Biogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biogen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 27.2B | 24.6B | 23.9B | 24.6B | 26.8B | 28.2B | |
Short Long Term Debt Total | 6.4B | 7.8B | 7.6B | 6.6B | 7.3B | 7.7B | |
Other Current Liab | 3.4B | 3.3B | 3.3B | 2.8B | 838.4M | 969.8M | |
Total Current Liabilities | 4.9B | 3.7B | 4.3B | 3.3B | 3.4B | 3.6B | |
Total Stockholder Equity | 13.3B | 10.7B | 11.0B | 13.4B | 14.8B | 15.5B | |
Property Plant And Equipment Net | 3.7B | 3.8B | 3.8B | 3.7B | 3.7B | 3.9B | |
Net Debt | 3.5B | 6.5B | 5.3B | 3.2B | 6.3B | 6.6B | |
Retained Earnings | 16.5B | 14.0B | 13.9B | 16.5B | 17.6B | 18.5B | |
Cash | 2.9B | 1.3B | 2.3B | 3.4B | 1.0B | 723.1M | |
Non Current Assets Total | 18.9B | 17.7B | 16.0B | 14.8B | 20.0B | 21.0B | |
Non Currrent Assets Other | (3.2B) | (1.4B) | 1.9B | 1.5B | 284.3M | 270.1M | |
Cash And Short Term Investments | 4.5B | 2.6B | 3.8B | 4.9B | 1.0B | 1.5B | |
Net Receivables | 1.9B | 1.9B | 1.5B | 2.1B | 2.1B | 2.2B | |
Common Stock Shares Outstanding | 187.4M | 161.3M | 149.6M | 146M | 145.6M | 283.0M | |
Liabilities And Stockholders Equity | 27.2B | 24.6B | 23.9B | 24.6B | 26.8B | 28.2B | |
Non Current Liabilities Total | 9.0B | 10.2B | 8.6B | 7.9B | 8.6B | 9.0B | |
Other Current Assets | 1.2B | 1.3B | 1.2B | 1.4B | 1.2B | 1.2B | |
Other Stockholder Equity | (3.0B) | (3.0B) | (2.8B) | (2.9B) | (2.7B) | (2.5B) | |
Total Liab | 13.9B | 13.9B | 12.9B | 11.2B | 12.0B | 12.6B | |
Property Plant And Equipment Gross | 3.7B | 3.8B | 3.8B | 3.7B | 6.1B | 6.4B | |
Total Current Assets | 8.4B | 6.9B | 7.9B | 9.8B | 6.9B | 7.2B | |
Accumulated Other Comprehensive Income | (135.2M) | (299M) | (106.7M) | (164.9M) | (153.7M) | (146.0M) | |
Intangible Assets | 3.5B | 3.1B | 2.2B | 1.9B | 8.4B | 8.8B | |
Accounts Payable | 530.8M | 454.9M | 589.2M | 491.5M | 403.3M | 423.5M | |
Short Term Investments | 2.3B | 1.6B | 1.3B | 1.5B | 1.5B | 0.0 | |
Inventory | 804.2M | 1.1B | 1.4B | 1.3B | 2.5B | 2.7B | |
Other Liab | 4.2B | 2.4B | 2.0B | 1.3B | 1.5B | 969.6M | |
Other Assets | 3.2B | 4.2B | 3.4B | 1.7B | 1.9B | 2.0B | |
Long Term Debt | 4.5B | 7.4B | 6.3B | 6.3B | 6.8B | 7.1B | |
Property Plant Equipment | 3.2B | 3.4B | 3.4B | 3.3B | 3.8B | 2.1B | |
Good Will | 5.8B | 5.8B | 5.8B | 5.7B | 6.2B | 3.2B | |
Net Tangible Assets | 4.1B | 1.9B | 2.9B | 5.8B | 6.7B | 4.1B | |
Noncontrolling Interest In Consolidated Entity | (4.1M) | (14.2M) | 63.5M | (9.5M) | (8.6M) | (8.1M) | |
Retained Earnings Total Equity | 16.5B | 14.0B | 13.9B | 16.5B | 18.9B | 11.5B |
Biogen Investors Sentiment
The influence of Biogen's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Biogen. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Biogen's public news can be used to forecast risks associated with an investment in Biogen. The trend in average sentiment can be used to explain how an investor holding Biogen can time the market purely based on public headlines and social activities around Biogen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Biogen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Biogen's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Biogen's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Biogen.
Biogen Implied Volatility | 26.18 |
Biogen's implied volatility exposes the market's sentiment of Biogen Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Biogen's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Biogen stock will not fluctuate a lot when Biogen's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biogen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biogen's short interest history, or implied volatility extrapolated from Biogen options trading.
Pair Trading with Biogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will appreciate offsetting losses from the drop in the long position's value.Moving together with Biogen Stock
0.62 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against Biogen Stock
0.77 | INDP | Indaptus Therapeutics | PairCorr |
0.59 | FBRX | Forte Biosciences Earnings Call Today | PairCorr |
0.51 | NUVB | Nuvation Bio | PairCorr |
0.41 | JSPR | Jasper Therapeutics | PairCorr |
The ability to find closely correlated positions to Biogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biogen Inc to buy it.
The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.011 | Earnings Share 8 | Revenue Per Share 66.688 | Quarterly Revenue Growth (0.07) | Return On Assets 0.0486 |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.